Harvard Apparatus Regenerative Tech Inc  

(Public, NASDAQ:HART)   Watch this stock  
Find more results for JOHN F. MCNAUGHTON
-0.15 (-4.55%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.08 - 3.29
52 week 1.85 - 10.82
Open 3.27
Vol / Avg. 67,432.00/192,245.00
Mkt cap 32.42M
P/E     -
Div/yield     -
EPS -1.39
Shares 9.68M
Beta     -
Inst. own 30%
Mar 19, 2015
Q4 2014 Harvard Apparatus Regenerative Technology Inc Earnings Call - Webcast
Mar 19, 2015
Q4 2014 Harvard Apparatus Regenerative Technology Inc Earnings Release
Jan 14, 2015
Harvard Apparatus Regenerative Technology Inc at EBD Biotech Showcase
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -134000.00% -40077.27%
Operating margin -133800.00% -40077.27%
EBITD margin - -39359.09%
Return on average assets -101.90% -113.75%
Return on average equity -109.92% -120.81%
Employees 20 -
CDP Score - -


84 October Hill Rd Ste 11
HOLLISTON, MA 01746-1371
United States - Map
+1-508-8938999 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Harvard Apparatus Regenerative Technology, Inc. is clinical stage regenerative medicine company developing life-saving medical devices. The Company�s products include Hollow Organ Bioreactors, Solid Organ Bioreactors, Scaffolds, and Clinical Infusion Pump. The Company�s first products are a bioreactor and a synthetic scaffold that can be used by surgeons to create a replacement trachea, or airway, for patients who need an airway transplant. Its bioreactor technology has been used in six human airway transplant surgeries. Its r products are in development. The Company�s products address the critical challenges to trachea transplant, the shortage of suitable donor tracheas. The Company is a wholly owned subsidiary Harvard Bioscience Inc. In October 2013, Harvard Bioscience Inc announced the spin-off of its wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc.

Officers and directors

David M. Green Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Thomas McNaughton Jr. Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Saverio La Francesca M.D. Chief Medical Officer
Bio & Compensation  - Reuters
Chane Graziano Director
Bio & Compensation  - Reuters
John F. Kennedy Independent Director
Age: 65
Bio & Compensation  - Reuters
James J. McGorry Independent Director
Age: 58
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 55
Bio & Compensation  - Reuters